Publication & Citation Trends
Publications
249 total
Maintenance Therapy with Belantamab, Pomalidomide and Dexamethasone in High-risk Myeloma Patients: A Phase 2 Study with a Safety Run-in - Interim Analysis
Cited by 0
Semantic Scholar
Prospective molecular monitoring of minimal residual disease after non-myeloablative allografting in newly diagnosed multiple myeloma OA
Cited by 36
Semantic Scholar
Carfilzomib, Cyclophosphamide and dexamethasone (CCD) for newly diagnosed multiple myeloma (MM) patients: initial results of a multicenter, open label phase II study
Cited by 2
Semantic Scholar
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma PDF
Cited by 309
OpenAlex
Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial PDF
Cited by 321
OpenAlex
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study
Cited by 819
OpenAlex
Efficacy and safety of once-weekly bortezomib in multiple myeloma patients PDF
Cited by 381
OpenAlex
Research Topics
Multiple Myeloma Research and Treatments
(227)
Cancer Treatment and Pharmacology
(94)
Protein Degradation and Inhibitors
(86)
Peptidase Inhibition and Analysis
(33)
Cancer therapeutics and mechanisms
(31)
Affiliations
Loyola University Medical Center
University of Milan
John H. Stroger, Jr. Hospital of Cook County
Casa Sollievo della Sofferenza
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico